PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3632/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A cardiac expert complained about what was described as a webinar/video on initiating Lixiana (edoxaban) hosted on a learned society webpage.The complainant alleged the video focused on renal funct…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3634/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A cardiac specialist complained about a Daiichi Sankyo promotional leavepiece for UK prescribers on how to initiate Lixiana (edoxaban) (EDX/22/0161; date of preparation March 2022).The complainant …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3642/5/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Clause 4.9 after Entresto sponsored BJC supplement articles omitted adverse event
An anonymous, contactable complainant (self-described cardiac specialist) complained about five Novartis-initiated and funded promotional articles/supplements about Entresto (sacubitril/valsartan) …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3625/3/22
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan
A prescribing pharmacist complained that Allergan used its medical device website (Juvéderm UK) to indirectly promote its prescription only medicine (Botox) across digital and social media channel…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3599/1/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca employee’s LinkedIn ‘like’ and comment held to be POM advertising to the public (AUTH/35
A hospital consultant complained about two LinkedIn items involving an AstraZeneca employee: (1) the employee’s own post about a blood pressure (BP) study; and (2) the employee ‘liking’ and c…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3639/4/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche Products Ltd – Polivy dosing webpage omitted key administration instructions (AUTH/3639/4/22)
An anonymous health professional complained about Roche’s Polivy (polatuzumab vedotin) promotional website, specifically the dosing page (GB-00004744; date of preparation September 2021).The comp…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3641/4/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva breached ABPI Code over DuoResp Spiromax website
An anonymous, contactable complainant (a health professional) raised concerns about the DuoResp Spiromax (budesonide/formoterol) website, particularly when viewed on a mobile device.The complaint a…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3651/5/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Roche
An anonymous, contactable health professional complained about the Ocrevus (ocrelizumab) landing page on the Roche Resources website.The landing page included the claim: “Ocrevus was generally we…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3647/5/22
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo
Leo made a voluntary admission about uncertified promotional material on the Kyntheum (brodalumab) promotional website (Dermaworld).Issue identified during Leo’s investigation connected to an ear…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3666/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached ABPI Code over HSJ sponsored article transparency (AUTH/3666/6/22)
An anonymous health professional complained about an online article in the Health Service Journal (HSJ) published on World Stroke Day (29 October 2019) titled “Addressing variations in the diagno…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3637/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant challenged Daiichi Sankyo’s myldltreatment patient website for people prescribed Nilemdo (bempedoic acid) or Nustendi (bempedoic acid/ezetimibe).The complainant alleged t…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3635/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis Entresto podcast
An anonymous cardiac specialist health professional complained about Episode 2 of Novartis’ ‘Heart to Heart’ podcast series promoting Entresto (sacubitril/valsartan).The podcast was developed…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3654/5/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
A health professional complained about a Novartis promotional symposium video for Entresto (sacubitril/valsartan) hosted on a learned society’s website after a September 2021 conference (video ML…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3663/6/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
An anonymous, contactable complainant (self-described health professional) alleged off-label promotion of Ocrevus (ocrelizumab) on Roche Products Ltd’s “Roche Resources” website.The complaint…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3667/6/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A health professional complained about a Roche Resources website page in the “Congresses and Meetings” section (“Future Positive Lite”; ref M-GB-00005336, date of preparation November 2021)…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3628/4/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
An anonymous, contactable complainant (a health professional) complained about six press releases in the news section of Novartis’ UK corporate website. The complainant alleged Novartis was proac…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3638/4/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis breached ABPI Code over ‘Think Symptom-free’ claim for Xolair on HCP website (AUTH/3638/4/2
A healthcare professional complained about promotional messaging for Xolair (omalizumab) on Novartis’ UK HCP website (health.novartis.co.uk), covering pages for Chronic Spontaneous Urticaria (CSU…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3643/5/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis breached Code over Kesimpta SMC “approval” stamp and UK digital ad (missing ‘adult’ + NI pr
An anonymous, contactable health professional complained about Kesimpta (ofatumumab) promotion on: (1) a Novartis product webpage (ref 199247, April 2021) and (2) a digital banner advertisement (re…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3648/5/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
An anonymous complainant challenged a December 2020 “Heart Failure Primary Care Leaders Network” virtual meeting and a 5-page meeting write-up hosted on a healthcare organisation’s website. T…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3652/5/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A named complainant alleged disguised promotion of MSD’s chickenpox vaccine in the Politico London Playbook (issue dated 24 May 2022) and the linked microsite stopthespots.co.uk. The Playbook car…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3655/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Code over Mayzent web page implying initiation was suitable for patients with rece
An anonymous health professional complained about the ‘Dosing and administration’ page for Mayzent (siponimod) on www.health.novartis.co.uk (UK | January 2021 | 104535).The page’s ‘Addition…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3661/6/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca breached Clause 8.1 over Forxiga website certification differences between desktop and m
An anonymous, contactable health professional complained about certification of the Forxiga (dapagliflozin) diabetes webpage on www.forxiga.co.uk.The complainant alleged the desktop and mobile vers…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3668/6/22
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Galapagos
A health professional complained about promotional claims on Galapagos UK’s HCP website for Jyseleca (filgotinib): strengthofbalance.co.uk.The homepage banner stated: “Strength of Balance” an…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3669/6/22
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Small Pharma website
An anonymous, contactable complainant (a health professional) challenged content on Small Pharma’s open-access website (smallpharma.com).The complainant alleged there was no clear delineation of …
Clauses: NONE
2022 🔒 Subscribe
← Prev 5 6 7 8 9 10 11 Next → Page 8 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews